
ALUR
Healthcare · Medical Devices · $1,215 market cap
$0.00200.00 (0.0%)Nov 13, 9:30 AM EST
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Jun 30, 2026
EPS trend, 90 days to now · +28.3% over 90 days · 30-day revisions 1 up, 0 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| May 20, 2026 | Time not confirmed | -5.10 | -6.90 | -35.3% |
| Mar 19, 2026 | Time not confirmed | -9.45 | -5.44 | +42.4% |
| Nov 12, 2025 | Time not confirmed | -0.10 | -1.53 | -1430.0% |
| Aug 19, 2025 | Time not confirmed | -0.13 | -1.28 | -884.6% |
| May 15, 2025 | Time not confirmed | -0.19 | 0.20 | +205.3% |
| Mar 27, 2025 | Time not confirmed | -0.17 | -7.94 | -4570.6% |
| Nov 13, 2024 | Before the open | -0.18 | -0.18 | -1.0% |
| Aug 13, 2024 | Before the open | -0.24 | -0.05 | +79.2% |
| May 14, 2024 | Before the open | -0.30 | 0.11 | +136.7% |
| Mar 26, 2024 | After the close | -0.51 | -0.40 | +20.9% |
| Nov 29, 2023 | Time not confirmed | — | -203.47 | — |
| Apr 4, 2023 | Time not confirmed | — | 0.02 | — |
| Nov 21, 2022 | Time not confirmed | — |
Allurion Technologies Inc. focuses on developing a weight loss platform for overweight people in Spain, France, Turkey, and internationally. Its Allurion Program platform offers the Allurion Smart Capsule, a swallowable and procedure-less intragastric balloon for weight loss, and access to the Allurion Virtual Care Suite, a digital therapeutic that combines AI-powered remote patient monitoring tools with a behavior…
| 0.08 |
| — |
| Aug 15, 2022 | Time not confirmed | — | 0.09 | — |
| May 13, 2022 | Time not confirmed | — | 0.12 | — |
| Mar 31, 2022 | Time not confirmed | — | 0.02 | — |
| Nov 19, 2021 | Time not confirmed | — | 0.18 | — |
| Aug 16, 2021 | Time not confirmed | — | -0.10 | — |
| May 24, 2021 | Time not confirmed | — | -0.05 | — |